During the corresponding time, Collegium Pharmaceutical Inc recorded a revenue increase by 6.67 % year on year, sequentially revenue grew by 45.63 %. While revenue at the Collegium Pharmaceutical Inc 's corporate clients
Collegium Pharmaceutical Inc's Comment on Sales, Marketing and Customers
The company operates in the United States, serving the ADHD and moderate to severe pain markets. Its product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR, and Symproic. Jornay PM, acquired through Ironshore, is a central nervous system stimulant approved for patients aged six years and older to treat ADHD. Belbuca is approved for managing severe and persistent pain requiring extended opioid treatment. Xtampza ER is an abuse-deterrent, extended-release oxycodone formulation used for pain management. Ironshore is identified as a customer and market in company filings.
Collegium Pharmaceutical Inc’s Comment on Sales, Marketing and Customers
The company operates in the United States, serving the ADHD and moderate to severe pain markets. Its product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR, and Symproic. Jornay PM, acquired through Ironshore, is a central nervous system stimulant approved for patients aged six years and older to treat ADHD. Belbuca is approved for managing severe and persistent pain requiring extended opioid treatment. Xtampza ER is an abuse-deterrent, extended-release oxycodone formulation used for pain management. Ironshore is identified as a customer and market in company filings.
Sources:
Collegium Pharmaceutical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Collegium Pharmaceutical Inc’s corporate clients.
For your research, we’ve provided 9 tables on Collegium Pharmaceutical Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
55.19 %